pimonidazole has been researched along with Canine Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Rooster, H; Dierckx, R; Ducatelle, R; Loomans, S; Mees, G; Pauwels, P; Peremans, K; Van Damme, N; Van de Wiele, C; Van Goethem, B; Vangestel, C | 1 |
| Chou, SC; Ji, X; Kleiter, MM; Lee, DY; Malarkey, DE; Raleigh, JA; Thrall, DE | 1 |
| Azuma, C; Raleigh, JA; Thrall, DE | 1 |
3 other study(ies) available for pimonidazole and Canine Diseases
| Article | Year |
|---|---|
Metabolic correlates of tumour hypoxia in malignant canine mammary carcinoma.
Topics: Animals; Dog Diseases; Dogs; Female; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Immunohistochemistry; Mammary Neoplasms, Animal; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Staining and Labeling | 2011 |
A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker.
Topics: Administration, Oral; Animals; Area Under Curve; Cell Hypoxia; Cell Line; Cricetinae; Cricetulus; Dog Diseases; Dogs; Feasibility Studies; Hydrogen-Ion Concentration; Injections, Intravenous; Neoplasms; Nitroimidazoles | 2006 |
Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime.
Topics: Animals; Cell Survival; DNA Adducts; DNA, Neoplasm; Dog Diseases; Dogs; Hypoxia; Neoplasms; Nitroimidazoles | 1997 |